In a strategic pivot, Chick-fil-A announces a modification to its chicken antibiotic policy, moving from a “No Antibiotics Ever” (NAE) stance to a “No Antibiotics Important To Human Medicine” (NAIHM) approach. This shift, prompted by concerns over potential supply shortages and the aim to maintain high animal welfare standards, underscores the complex interplay between food production practices, public health, and consumer expectations in the fast-food industry.